Skip to main content
. Author manuscript; available in PMC: 2022 May 12.
Published in final edited form as: Lancet Oncol. 2017 Dec 21;19(2):257–266. doi: 10.1016/S1470-2045(17)30912-9

Figure 3. Overall Survival, Progression Free Survival and Duration of Response.

Figure 3.

Time-to-event points for patients in the Phase 1 and 2 treated with BvB. In all cases, the red curve in each panel represents the results from the Phase 2.